SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001485003-21-000083
Filing Date
2021-04-07
Accepted
2021-04-07 08:03:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a04072021.htm DEFA14A 37184
2 GRAPHIC ex991issandglasslewispre001.jpg GRAPHIC 263222
3 GRAPHIC ex991issandglasslewispre002.jpg GRAPHIC 279768
4 GRAPHIC ex991issandglasslewispre003.jpg GRAPHIC 300596
5 GRAPHIC sesnformissandglasslewis001.jpg GRAPHIC 99541
6 GRAPHIC sesnformissandglasslewis002.jpg GRAPHIC 96226
7 GRAPHIC sesnformissandglasslewis003.jpg GRAPHIC 64276
8 GRAPHIC sesnformissandglasslewis004.jpg GRAPHIC 43482
  Complete submission text file 0001485003-21-000083.txt   1618958
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 21810714
SIC: 2834 Pharmaceutical Preparations